Subsequent Events (Details) - Subsequent Event - AUG Therapeutics, LLC - Purchase Agreement $ in Thousands |
Oct. 27, 2023
USD ($)
|
|---|---|
| Subsequent Event [Line Items] | |
| Upfront payment paid | $ 150 |
| Contingent milestone payment | 15,000 |
| Maximum potential payments | $ 45,000 |
| Contingent milestone upfront payment percentage | 0.20 |
| Asset acquisition consideration transferred, liabilities | $ 150 |
| X | ||||||||||
- Definition Asset Acquisition Consideration Transferred, Liabilities No definition available.
|
| X | ||||||||||
- Definition Contingent Milestone Payment No definition available.
|
| X | ||||||||||
- Definition Contingent Milestone Upfront Payment Percentage No definition available.
|
| X | ||||||||||
- Definition Maximum Potential Payments No definition available.
|
| X | ||||||||||
- Definition Upfront Payment Paid No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|